Document Classification

Section Type: RESULTS

Text: Treatment with GH produced a significant reduction in plasma TNF-alpha (7. 8 + / -1. 1 versus 5. 5 + / -0. 9 pg/ml, P < 0. 02), sTNFRI (4. 0 + / -0. 4 versus 3. 3 + / -0. 3 ng/ml, P < 0. 05), sTNFRII (2. 8 + / -0. 3 versus 2. 4 + / -0. 2 ng/ml, P < 0. 05), sFas (4. 7 + / -0. 7 versus 3. 3 + / -0. 5 ng/ml, P < 0. 05) and sFasL (33. 5 + / -9. 7 versus 20. 2 + / -6. 2 pg/ml, P < 0. 01).